Clinical Trial Update: Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hydroxyurea for primary desmoid tumors has been withdrawn. The study examined hydroxyurea as a treatment for desmoid tumors (desmoid-ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Tumor
• Desmoid-type Fibromatosis

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Desmoid Tumors, Fibromatosis | Phase 2 | Status: WITHDRAWN